ARCHIVES

Arimidex Reduces Relapse Compared To Tamoxifen, Large Study Reports

This article is from The Cancer Letter archive.

Vol. 24 No. 12 | December 28, 2001

Download PDF Visit The Full Archive

Related Articles

Cancer Genetics: risk from Three BRCA Mutations Lower Than Expected, NCI Finds

May 23, 1997

FDA Declares Taxol Orphan Drug For KS; Can IVAX Break Bristol’s Exclusivity?

August 15, 1997

International Group Plans Survey On Thrombosis Risk

July 27, 2001

Axitinib Shows Activity Against Advanced Thyroid Cancer

July 27, 2007

DCPC Board Okays Core Grant Changes On Shared Resources

January 30, 1987

After A One-Month Retirement, Becker Returns To M.D. Anderson As Research Prof.

November 30, 2001